Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency

About this update from Moss Genomics, Inc.

Vancouver, British Columbia--(Newsfile Corp. - February 25, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss Genomics") is pleased to provide an update on its business strategy and the continued development of its genomics-focused initiatives. As the Company advances its product roadmap, it remains committed to leveraging blockchain technology within its genomics platform while maintaining an Ethereum accumulation strategy as part of its treasury management.Moss Genomics is researching and developing technology where users can receive personalized insights on their health data. Moss Genomics aims to provide individuals with a deeper understanding and control over their health data. By leveraging the Ethereum blockchain, Moss Genomics aims to allow users to maintain full control over their health information.To support these efforts, the company has launched its new website, https://mossgenomics.com, where users can learn more about the company's genomics initiatives, sign up for product updates, and connect their Ethereum wallets in preparation for future blockchain-based features. As previously disclosed, as part of its treasury management strategy, the Company will continue to evaluate potential investments in the blockchain and cryptocurrency sectors from time to time, including the proposed Ethereum cryptocurrency (ETH") as disclosed in the Company's news release dated February 3, 2025. Management of the Company believes that ETH represents a viable alternative to traditional fiat currencies. The Company has existing arrangements with certain service providers which permit satisfaction of payment obligations in ETH and management anticipates entering into similar arrangements in the future. The Company believes that its Ethereum treasury division is complementary to its existing business model by providing the Company with an alternative source of financing, access to a different investor base in the Ethereum community and potential for investment upside for its ETH holdings that exceed its short-term capital requirements. Should a suitable blockchain or cryptocurrency-related investment opportunity arise—one that is unrelated to its genomics business or Ethereum treasury strategy—the Company may consider applying to the CSE to complete a change of business to that of an investment issuer. Until such time, Moss Genomics remain...

View stock analysis, news, and events for Moss Genomics, Inc.